ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $22,787,000 | +204.0% | 563,753 | +332.8% | 0.05% | +206.7% |
| Q2 2015 | $7,496,000 | -6.1% | 130,251 | +3.9% | 0.02% | -16.7% |
| Q1 2015 | $7,981,000 | +14.6% | 125,347 | +11.1% | 0.02% | +20.0% |
| Q4 2014 | $6,967,000 | +305.5% | 112,847 | +155.0% | 0.02% | +200.0% |
| Q3 2014 | $1,718,000 | -65.8% | 44,247 | -69.7% | 0.01% | -64.3% |
| Q2 2014 | $5,024,000 | +108.3% | 145,847 | +161.3% | 0.01% | +100.0% |
| Q1 2014 | $2,412,000 | -3.6% | 55,819 | -11.1% | 0.01% | 0.0% |
| Q4 2013 | $2,503,000 | +11.0% | 62,819 | +4.6% | 0.01% | -12.5% |
| Q3 2013 | $2,255,000 | +83.8% | 60,072 | +31.5% | 0.01% | +100.0% |
| Q2 2013 | $1,227,000 | +96.3% | 45,672 | -23.5% | 0.00% | +33.3% |
| Q4 2012 | $625,000 | – | 59,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |